CBD industry stakeholders should not accept the UK Food Standards Agency’s recent downgrading of the CBD Acceptable Daily Intake (ADI), with recent studies advancing our understanding and potentially opening up opportunities to push for higher levels.
Holland & Barrett has reinstated 31 CBD products that were temporarily removed from sale in response to the UK FSA's new consumer guidance which reduced daily recommended intakes for CBD down from 70mg to 10mg.
Food law experts concerned about CBD novel foods process as FSA reveals first products list Food law experts have voiced their concerns over the novel foods process for CBD products as the FSA publishes its long-awaited, but somewhat short, list of products allowed to remain on the market.
The list contains 22 products from just three companies: Chanelle McCoy Health (Pureis), CANNABIS Pharma s.r.o, and Health Innovations (UK) ltd.
Companies in England and Wales had to submit their novel foods dossiers to the FSA by March 31st if they wanted their CBD products to be able to legally remain on the market.